Uncategorized

Merck adds to biopharma’s AI agenda with up to $510M+ Protillion pact

Published

5 hours ago

on

June 17, 2026

By

Temp User

Merck will use Protillion Biosciences’ tech to design biologic therapies for therapies across undisclosed indications.

Related Topics:

Leave a Reply

Uncategorized9 years ago

These ’90s fashion trends are making a comeback in 2017
Uncategorized9 years ago

According to Dior Couture, this taboo fashion accessory is back
Endpoints News3 months ago

Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
Uncategorized9 years ago

Phillies’ Aaron Altherr makes mind-boggling barehanded play
Uncategorized9 years ago

Uber and Lyft are finally available in all of New York State
Uncategorized9 years ago

Steph Curry finally got the contract he deserves from the Warriors

Exit mobile version